Theodore L. Harris - Feb 12, 2025 Form 4/A - Amendment Insider Report for BALCHEM CORP (BCPC)

Signature
/s/ Travis Larsen, Attorney in Fact for Theodore L Harris
Stock symbol
BCPC
Transactions as of
Feb 12, 2025
Transactions value $
-$1,866,648
Form type
4/A - Amendment
Date filed
4/11/2025, 06:08 PM
Date Of Original Report
Feb 14, 2025
Previous filing
Feb 12, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +6.6K +10.71% $0.00 68.2K Feb 12, 2025 Direct F1
transaction BCPC Common Stock Award $0 +22.4K +32.77% $0.00 90.6K Feb 13, 2025 Direct F2
transaction BCPC Common Stock Tax liability -$1.87M -11.4K -12.63% $163.14 79.2K Feb 13, 2025 Direct F3
holding BCPC Common Stock 1.87K Feb 12, 2025 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +21.5K $0.00 21.5K Feb 12, 2025 Common Stock 21.5K $159.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Represents the vesting of performance stock units (includes 369 dividend equivalent shares) for the 2022-2024 performance period.
F3 11,442 of 22,364 the performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
F4 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Remarks:

This Form 4/A amends and restates the original Form 4 filed on February 14, 2025, which inadvertently noted the vesting period for restricted stock as 3 years from the grant date, instead of a ratable vesting over a 3-year period.